BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 205 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $55,881,000 | -24.2% | 635,302 | -16.3% | 0.58% | -21.1% |
| Q1 2021 | $73,768,000 | -48.2% | 758,691 | -40.3% | 0.73% | -35.7% |
| Q4 2020 | $142,490,000 | +12.6% | 1,270,529 | -6.9% | 1.13% | +18.3% |
| Q3 2020 | $126,501,000 | +18.8% | 1,364,631 | 0.0% | 0.96% | -1.5% |
| Q2 2020 | $106,441,000 | +12.8% | 1,364,631 | -15.4% | 0.97% | -23.5% |
| Q1 2020 | $94,345,000 | -21.7% | 1,613,294 | +7.2% | 1.27% | -15.3% |
| Q4 2019 | $120,533,000 | +9.5% | 1,504,599 | +0.4% | 1.50% | -0.8% |
| Q3 2019 | $110,096,000 | -22.1% | 1,498,516 | 0.0% | 1.51% | -52.1% |
| Q2 2019 | $141,355,000 | +17.8% | 1,498,516 | 0.0% | 3.16% | -5.4% |
| Q1 2019 | $119,956,000 | +55.5% | 1,498,516 | +4.7% | 3.34% | +4.4% |
| Q4 2018 | $77,142,000 | – | 1,430,949 | – | 3.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |